In the context of cancer, hormonal agents are particularly significant for cancers that are sensitive to hormones. For instance, breast cancer cells that express estrogen receptors (ER-positive) can be treated with agents like tamoxifen or aromatase inhibitors. Similarly, prostate cancer can be treated with androgen deprivation therapy (ADT), which lowers or blocks the action of male hormones that stimulate cancer growth.
